Chardan: Esperion Therapeutics Still A Sell By: Benzinga via Benzinga August 07, 2015 at 11:30 AM EDT In a report published Friday, Chardan Capital analyst Gbola Amusa reiterated a Sell rating on Esperion Therapeutics, Inc. (NASDAQ: ... Read More >> Related Stocks: Esperion Theraptc Takeda Pharma